Source:http://linkedlifedata.com/resource/pubmed/id/17352736
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-13
|
pubmed:abstractText |
The rare hereditary disorder Fanconi anemia (FA) can be caused by mutations in components of the FA core complex (FancA/B/C/E/F/G/L/M), a key regulator FancD2, the breast cancer susceptibility protein BRCA2/FancD1, or the newly identified FancJ/BRIP1 helicase. By performing yeast two-hybrid (Y2H) screens using N-terminal chicken (ch) FancD2 as a bait, we have identified chFancL, the likely ubiquitin E3 ligase subunit of the FA core complex. We also found that ectopically expressed FancD2 and FancL co-immunoprecipitated in 293T cells, and this interaction was dependent on the PHD domain of FancL. FANCL-disrupted chicken DT40 cells displayed defects in both FancD2 monoubiquitination and focus formation. Importantly, cell lines lacking the FANCL or FANCD2 genes, or carrying a "knock-in" mutation of the FancD2 monoubiquitination site (where the Lys 563 residue is changed to Arg), displayed quantitatively identical defects in the repair of I-SceI-induced chromosomal breaks by homologous recombination (HR). These data establish the role of FANCL and FancD2 monoubiquitination in HR repair.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Fanconi Anemia Complementation...,
http://linkedlifedata.com/resource/pubmed/chemical/Fanconi Anemia Complementation...,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1356-9597
|
pubmed:author |
pubmed-author:HiranoSeikiS,
pubmed-author:IshiaiMasamichiM,
pubmed-author:KashiharaNaokiN,
pubmed-author:KitaoHiroyukiH,
pubmed-author:MatsushitaNobukoN,
pubmed-author:OdaTsukasaT,
pubmed-author:OhzekiMiokoM,
pubmed-author:SekiSohsukeS,
pubmed-author:TakataMinoruM,
pubmed-author:TsubaharaAkioA,
pubmed-author:UchidaAkikoA,
pubmed-author:YamashitaTakayukiT
|
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
299-310
|
pubmed:meshHeading |
pubmed-meshheading:17352736-Animals,
pubmed-meshheading:17352736-Cell Line,
pubmed-meshheading:17352736-Chickens,
pubmed-meshheading:17352736-DNA Repair,
pubmed-meshheading:17352736-Fanconi Anemia,
pubmed-meshheading:17352736-Fanconi Anemia Complementation Group D2 Protein,
pubmed-meshheading:17352736-Fanconi Anemia Complementation Group L Protein,
pubmed-meshheading:17352736-Humans,
pubmed-meshheading:17352736-Mutation,
pubmed-meshheading:17352736-Recombinant Proteins,
pubmed-meshheading:17352736-Two-Hybrid System Techniques,
pubmed-meshheading:17352736-Ubiquitin
|
pubmed:year |
2007
|
pubmed:articleTitle |
A requirement of FancL and FancD2 monoubiquitination in DNA repair.
|
pubmed:affiliation |
Department of Immunology and Molecular Genetics, Kawasaki Medical School, Kurashiki, Okayama 701-0192, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|